Optionsscheine finden
Nähere Informationen zum Handelssegment EASY EUWAX finden Sie hier.
► Tipp: Abonnieren Sie unsere Newsletter, um immer auf dem Laufenden bei aktuellen Wertpapierentwicklungen zu bleiben.
Ihre Auswahl:
317 Ergebnisse
| MN022K |  | Bristol-Myers Squibb Co./OS/Call [50]/MS | - | - | 50,000 | call | Bristol-Myers Squibb Co. | - | 39,406 % | 0,722 | -0,005 | 2,738 | 17.12.2027 | 0,100 | Morgan Stanley | |
| MR16M1 | | Bristol-Myers Squibb Co./OS/Call [50]/MS | - | - | 50,000 | call | Bristol-Myers Squibb Co. | - | 38,722 % | 0,771 | -0,007 | 3,484 | 19.03.2027 | 0,100 | Morgan Stanley | |
| FA1BQN | Bristol-Myers Squibb Co./OS/Call [50]/SOC | - | - | 50,000 | call | Bristol-Myers Squibb Co. | - | 38,776 % | 0,787 | -0,007 | 3,814 | 15.01.2027 | 0,100 | Société Générale | ||
| FA53CA | Bristol-Myers Squibb Co./OS/Call [50]/SOC | - | - | 50,000 | call | Bristol-Myers Squibb Co. | - | 38,521 % | 0,813 | -0,009 | 3,983 | 18.12.2026 | 0,100 | Société Générale | ||
| FD1Y4N | Bristol-Myers Squibb Co./OS/Call [50]/SOC | - | - | 50,000 | call | Bristol-Myers Squibb Co. | - | 37,444 % | 0,774 | -0,007 | 3,558 | 19.03.2027 | 0,100 | Société Générale | ||
| FD1YPK | Bristol-Myers Squibb Co./OS/Call [50]/SOC | - | - | 50,000 | call | Bristol-Myers Squibb Co. | - | - | - | - | - | 18.09.2026 | 0,100 | Société Générale | ||
| UN3J2V | | Bristol-Myers Squibb Co./OS/Call [50]/UniCredit | - | - | 50,000 | call | Bristol-Myers Squibb Co. | - | 40,437 % | 0,783 | -0,008 | 3,763 | 13.01.2027 | 0,100 | Unicredit | |
| UN9X0M | | Bristol-Myers Squibb Co./OS/Call [50]/UniCredit | - | - | 50,000 | call | Bristol-Myers Squibb Co. | - | 35,948 % | 0,755 | -0,006 | 3,324 | 16.06.2027 | 0,100 | Unicredit | |
| VH50E9 | | Bristol-Myers Squibb Co./OS/Call [50]/VONT | - | - | 50,000 | call | Bristol-Myers Squibb Co. | - | 41,550 % | 0,783 | -0,008 | 3,644 | 15.01.2027 | 0,100 | Vontobel | |
| MK5REM | | Bristol-Myers Squibb Co./OS/Call [52,5]/MS | - | - | 52,500 | call | Bristol-Myers Squibb Co. | - | 39,360 % | 0,754 | -0,010 | 4,232 | 18.12.2026 | 0,100 | Morgan Stanley | |
| MK9J50 | | Bristol-Myers Squibb Co./OS/Call [52,5]/MS | - | - | 52,500 | call | Bristol-Myers Squibb Co. | - | 36,285 % | 0,716 | -0,006 | 3,454 | 17.06.2027 | 0,100 | Morgan Stanley | |
| MM5G89 | | Bristol-Myers Squibb Co./OS/Call [52,5]/MS | - | - | 52,500 | call | Bristol-Myers Squibb Co. | - | 40,200 % | 0,836 | -0,016 | 5,521 | 18.09.2026 | 0,100 | Morgan Stanley | |
| PJ8XN3 | | Bristol-Myers Squibb Co./OS/Call [52]/BNP | - | - | 52,000 | call | Bristol-Myers Squibb Co. | - | 39,032 % | 0,857 | -0,015 | 5,453 | 18.09.2026 | 0,100 | BNP Paribas | |
| PK34Q4 | | Bristol-Myers Squibb Co./OS/Call [52]/BNP | - | - | 52,000 | call | Bristol-Myers Squibb Co. | - | 39,360 % | 0,765 | -0,010 | 4,210 | 18.12.2026 | 0,100 | BNP Paribas | |
| JY1EK9 | Bristol-Myers Squibb Co./OS/Call [54]/JPMD | - | - | 54,000 | call | Bristol-Myers Squibb Co. | - | 35,346 % | 0,740 | -0,010 | 4,728 | 18.12.2026 | 0,100 | JP Morgan | ||
| FD1YPN | Bristol-Myers Squibb Co./OS/Call [54]/SOC | - | - | 54,000 | call | Bristol-Myers Squibb Co. | - | 39,360 % | 0,697 | -0,009 | 4,281 | 15.01.2027 | 0,100 | Société Générale | ||
| PG5HFC | | Bristol-Myers Squibb Co./OS/Call [55]/BNP | - | - | 55,000 | call | Bristol-Myers Squibb Co. | - | 38,266 % | 0,696 | -0,011 | 4,717 | 18.12.2026 | 0,100 | BNP Paribas | |
| PL1KQH | | Bristol-Myers Squibb Co./OS/Call [55]/BNP | - | - | 55,000 | call | Bristol-Myers Squibb Co. | - | 39,123 % | 0,676 | -0,010 | 4,412 | 15.01.2027 | 0,100 | BNP Paribas | |
| PL678M | | Bristol-Myers Squibb Co./OS/Call [55]/BNP | - | - | 55,000 | call | Bristol-Myers Squibb Co. | - | 36,842 % | 0,774 | -0,017 | 6,599 | 18.09.2026 | 0,100 | BNP Paribas | |
| PG1RGP | | Bristol-Myers Squibb Co./OS/Call [55]/BNP | - | - | 55,000 | call | Bristol-Myers Squibb Co. | - | 35,966 % | 0,665 | -0,007 | 3,704 | 17.06.2027 | 0,100 | BNP Paribas | |
| PK0DLV | | Bristol-Myers Squibb Co./OS/Call [55]/BNP | - | - | 55,000 | call | Bristol-Myers Squibb Co. | - | 37,408 % | 0,674 | -0,008 | 4,046 | 19.03.2027 | 0,100 | BNP Paribas | |
| PK42U0 | | Bristol-Myers Squibb Co./OS/Call [55]/BNP | - | - | 55,000 | call | Bristol-Myers Squibb Co. | - | 36,477 % | 0,652 | -0,006 | 3,378 | 17.09.2027 | 0,100 | BNP Paribas | |
| PK42U2 | | Bristol-Myers Squibb Co./OS/Call [55]/BNP | - | - | 55,000 | call | Bristol-Myers Squibb Co. | - | 36,641 % | 0,647 | -0,005 | 3,137 | 17.12.2027 | 0,100 | BNP Paribas | |
| PK50NM | | Bristol-Myers Squibb Co./OS/Call [55]/BNP | - | - | 55,000 | call | Bristol-Myers Squibb Co. | - | 37,481 % | 0,642 | -0,005 | 3,030 | 21.01.2028 | 0,100 | BNP Paribas | |
| PK51Y8 | | Bristol-Myers Squibb Co./OS/Call [55]/BNP | - | - | 55,000 | call | Bristol-Myers Squibb Co. | - | 36,906 % | 0,645 | -0,005 | 2,940 | 17.03.2028 | 0,100 | BNP Paribas | |
| JF29MP | Bristol-Myers Squibb Co./OS/Call [55]/JPM | - | - | 55,000 | call | Bristol-Myers Squibb Co. | - | 35,747 % | 0,703 | -0,011 | 4,952 | 18.12.2026 | 0,100 | JP Morgan | ||
| JF3DN2 | Bristol-Myers Squibb Co./OS/Call [55]/JPM | - | - | 55,000 | call | Bristol-Myers Squibb Co. | - | 36,787 % | 0,681 | -0,009 | 4,616 | 15.01.2027 | 0,100 | JP Morgan | ||
| JH4RYN | Bristol-Myers Squibb Co./OS/Call [55]/JPM | - | - | 55,000 | call | Bristol-Myers Squibb Co. | - | 34,013 % | 0,796 | -0,015 | 6,702 | 18.09.2026 | 0,100 | JP Morgan | ||
| MJ8503 | | Bristol-Myers Squibb Co./OS/Call [55]/MS | - | - | 55,000 | call | Bristol-Myers Squibb Co. | - | 36,076 % | 0,710 | -0,011 | 4,829 | 18.12.2026 | 0,100 | Morgan Stanley | |
| MK9J51 | | Bristol-Myers Squibb Co./OS/Call [55]/MS | - | - | 55,000 | call | Bristol-Myers Squibb Co. | - | 36,203 % | 0,664 | -0,007 | 3,691 | 17.06.2027 | 0,100 | Morgan Stanley | |
| MM5G8A | | Bristol-Myers Squibb Co./OS/Call [55]/MS | - | - | 55,000 | call | Bristol-Myers Squibb Co. | - | 37,371 % | 0,769 | -0,018 | 6,557 | 18.09.2026 | 0,100 | Morgan Stanley | |
| MN022L | | Bristol-Myers Squibb Co./OS/Call [55]/MS | - | - | 55,000 | call | Bristol-Myers Squibb Co. | - | 37,645 % | 0,654 | -0,005 | 3,048 | 17.12.2027 | 0,100 | Morgan Stanley | |
| MN6CP3 | | Bristol-Myers Squibb Co./OS/Call [55]/MS | - | - | 55,000 | call | Bristol-Myers Squibb Co. | - | 36,751 % | 0,675 | -0,008 | 4,099 | 19.03.2027 | 0,100 | Morgan Stanley | |
| SX5KV0 | Bristol-Myers Squibb Co./OS/Call [55]/SOC | - | - | 55,000 | call | Bristol-Myers Squibb Co. | - | 38,667 % | 0,675 | -0,010 | 4,459 | 15.01.2027 | 0,100 | Société Générale | ||
| FA53CB | Bristol-Myers Squibb Co./OS/Call [55]/SOC | - | - | 55,000 | call | Bristol-Myers Squibb Co. | - | 36,222 % | 0,704 | -0,011 | 4,896 | 18.12.2026 | 0,100 | Société Générale | ||
| FD1Y4P | Bristol-Myers Squibb Co./OS/Call [55]/SOC | - | - | 55,000 | call | Bristol-Myers Squibb Co. | - | 35,127 % | 0,680 | -0,008 | 4,229 | 19.03.2027 | 0,100 | Société Générale | ||
| FD5GU5 | Bristol-Myers Squibb Co./OS/Call [55]/SOC | - | - | 55,000 | call | Bristol-Myers Squibb Co. | - | 34,397 % | 0,792 | -0,016 | 6,670 | 18.09.2026 | 0,100 | Société Générale | ||
| UN3U23 | | Bristol-Myers Squibb Co./OS/Call [55]/UniCredit | - | - | 55,000 | call | Bristol-Myers Squibb Co. | - | 37,399 % | 0,687 | -0,009 | 4,509 | 13.01.2027 | 0,100 | Unicredit | |
| VJ3CBV | | Bristol-Myers Squibb Co./OS/Call [55]/VONT | - | - | 55,000 | call | Bristol-Myers Squibb Co. | - | 36,605 % | 0,701 | -0,011 | 4,870 | 18.12.2026 | 0,100 | Vontobel | |
| VY3747 | | Bristol-Myers Squibb Co./OS/Call [55]/VONT | - | - | 55,000 | call | Bristol-Myers Squibb Co. | - | 39,123 % | 0,676 | -0,010 | 4,412 | 15.01.2027 | 0,100 | Vontobel | |
| VY46PN | | Bristol-Myers Squibb Co./OS/Call [55]/VONT | - | - | 55,000 | call | Bristol-Myers Squibb Co. | - | 35,117 % | 0,673 | -0,007 | 3,725 | 17.06.2027 | 0,100 | Vontobel | |
| VY8B9B | | Bristol-Myers Squibb Co./OS/Call [55]/VONT | - | - | 55,000 | call | Bristol-Myers Squibb Co. | - | 35,802 % | 0,678 | -0,008 | 4,171 | 19.03.2027 | 0,100 | Vontobel | |
| VY8CG2 | Bristol-Myers Squibb Co./OS/Call [55]/VONT | - | - | 55,000 | call | Bristol-Myers Squibb Co. | - | 35,492 % | 0,781 | -0,016 | 6,558 | 18.09.2026 | 0,100 | Vontobel | ||
| JE73P5 | Bristol-Myers Squibb Co./OS/Call [56]/JPMD | - | - | 56,000 | call | Bristol-Myers Squibb Co. | - | 35,054 % | 0,658 | -0,008 | 4,347 | 19.03.2027 | 0,100 | JP Morgan | ||
| JE8XWS | Bristol-Myers Squibb Co./OS/Call [56]/JPMD | - | - | 56,000 | call | Bristol-Myers Squibb Co. | - | 36,349 % | 0,655 | -0,009 | 4,805 | 15.01.2027 | 0,100 | JP Morgan | ||
| JY0S65 | Bristol-Myers Squibb Co./OS/Call [56]/JPMD | - | - | 56,000 | call | Bristol-Myers Squibb Co. | - | 35,127 % | 0,678 | -0,011 | 5,187 | 18.12.2026 | 0,100 | JP Morgan | ||
| JY2267 | Bristol-Myers Squibb Co./OS/Call [56]/JPMD | - | - | 56,000 | call | Bristol-Myers Squibb Co. | - | 37,061 % | 0,781 | -0,023 | 8,608 | 21.08.2026 | 0,100 | JP Morgan | ||
| FA1BQP | Bristol-Myers Squibb Co./OS/Call [56]/SOC | - | - | 56,000 | call | Bristol-Myers Squibb Co. | - | 38,521 % | 0,652 | -0,010 | 4,594 | 15.01.2027 | 0,100 | Société Générale | ||
| MK5RER | | Bristol-Myers Squibb Co./OS/Call [57,5]/MS | - | - | 57,500 | call | Bristol-Myers Squibb Co. | - | 36,276 % | 0,634 | -0,012 | 5,314 | 18.12.2026 | 0,100 | Morgan Stanley | |
| MK9J52 | | Bristol-Myers Squibb Co./OS/Call [57,5]/MS | - | - | 57,500 | call | Bristol-Myers Squibb Co. | - | 35,492 % | 0,619 | -0,007 | 3,941 | 17.06.2027 | 0,100 | Morgan Stanley |